Why Is IBM Stock Falling? Inside the 24% Plunge, Q2 Miss, and Whether It’s a 'Buy the Dip' Opportunity

IBM stock plunged more than 24% in trade today, July 14, 2026. The fall comes after IBM’s preliminary second-quarter numbers did something remarkable. A revenue miss of about $660 million erased roughly $65 billion of market value. The company expects Q2 revenue of $17.2 billion against the $17.86 billion LSEG consensus. Adjusted EPS are expected to be $2.93, below the consensus. 

The size of the reaction tells us that investors are not only worried about one weak quarter. They are questioning the strength of IBM’s software-led transformation, the quality of its growth and the reliability of its free cash flow.

Let’s break down in detail why IBM stock is falling today, whether the Q2 miss reflects delayed client spending or a deeper business problem, where IBM really stands in AI and quantum computing, and what investors should verify when full Q2 earnings arrive on July 22.

Why is IBM Stock Falling Today?

IBM was scheduled to publish its full Q2 results on July 22. Instead, it released preliminary figures eight days early. CEO Arvind Krishna acknowledged in his investor letter that IBM had “faltered.” The combination of an early warning, a direct admission of weak execution and lower-than-expected numbers made the announcement more serious than a routine earnings miss.

Sources: IBM’s preliminary Q2 investor letter, Reuters and IBM’s Q1 2026 earnings release.

What this means: The 3.7% revenue miss was manageable by itself. The more serious problem was the combination of slower software growth, weak infrastructure revenue and flat first-half cash generation.

What management says went wrong

IBM identified three main causes:

1. Clients shifted their budgets. Companies prioritised spending on scarce servers, storage and memory before expected price increases. Some software purchases were postponed.
2. IBM Z and Transaction Processing underperformed. This matters because mainframes and their associated software are central to IBM’s profit model.
3. Large deals did not close. Cybersecurity concerns distracted clients, while IBM admitted that it did not adapt quickly enough to the changing environment.

The first explanation could be a timing problem. Imagine an Indian manufacturer that intended to purchase both new machinery and management software. If the machinery became scarce and prices were about to rise, the company might buy the machinery first and postpone the software purchase. The software project has not necessarily disappeared, but investors need evidence that it will return.

The IBM Z and deal-execution problems are more company-specific. Managing mainframe product cycles and closing complex enterprise contracts are supposed to be IBM’s strengths.

There were some positive signals as well. Red Hat grew 11%. Distributed Infrastructure increased 37% and ended the quarter with approximately $500 million of backlog, meaning contracted demand that has not yet been recorded as revenue. IBM also said its z17 programme remains at nearly 130% of the comparable z16 cycle. These figures argue against a complete collapse in demand. They do not, however, resolve the software concern.

Why IBM Lost $65 Billion in Value Over a $660 Million Revenue Miss

A natural question is why a $660 million revenue shortfall could erase about $65.5 billion in market value. The answer is that share prices reflect expectations for many years of future profit, not only one quarter’s revenue.

At the maximum 24% decline:

• Previous close: $290.23
• Price after a 24% fall: $220
• Market value erased: $65.5 billion

The value loss was therefore almost 100 times the quarterly revenue shortfall. That does not mean the market treated $660 million of missing sales as being worth $65.5 billion. It means the miss caused investors to reduce their expectations for IBM’s future growth, margins and cash generation.

Why IBM’s Organic Software Growth Is the Biggest Concern

Software is particularly important because it is IBM’s most profitable major business.

Software produced approximately 45% of IBM’s 2025 revenue and, according to J.P. Morgan, close to two-thirds of its profit. In Q1 2026, Software had an 82.8% gross margin, compared with 27.5% for Consulting and 56.9% for Infrastructure.

Gross margin measures the percentage of revenue left after the direct cost of delivering a product or service. A high-margin software sale can therefore contribute much more profit than the same amount of consulting or hardware revenue. This is why slowing software growth matters more than the headline revenue miss suggests.

The Confluent question in IBM Math

IBM completed its acquisition of Confluent for approximately $11.6 billion in March. Before the warning, BofA estimated that Confluent could add about $340 million of Q2 revenue, equivalent to roughly 5% of software growth. IBM’s total preliminary software growth was also only 5%.

The following bridge uses BofA’s estimate to test how much growth may have come from IBM’s existing businesses.

IBM has not disclosed Q2 organic software growth. The calculation below is an estimate, not a confirmed company result. Currency movements, acquisition accounting and the actual Confluent contribution could change the answer.

Sources: IBM’s Q2 2025 earnings release and BofA’s Q2 preview.

If BofA’s estimate is close to the final result, roughly 92 cents of every additional software-revenue dollar came from Confluent rather than IBM’s existing software businesses.

This calculation helps explain the extreme share-price reaction. IBM entered the quarter expecting more than 10% full-year software growth. Investors had been paying a higher valuation because they expected IBM’s high-margin software engine to accelerate.

If acquisitions are providing nearly all the growth, the quality of that growth becomes less attractive.

Free cash flow creates another test

IBM generated $4.76 billion of free cash flow (FCF) in the first half, virtually unchanged from $4.8 billion a year earlier. FCF is the cash a business generates after paying operating expenses and capital expenditure.

Its previous guidance called for approximately $1 billion more FCF than 2025’s $14.73 billion. That implied a 2026 target of roughly $15.73 billion. Reaching that amount would now require approximately $10.97 billion in the second half, about 10% more than IBM generated in H2 2025. IBM is normally stronger in the second half, so this is possible but not guaranteed.

That makes the July 22 free cash flow update more important than the preliminary EPS figure.

Where IBM Stands in AI, Hybrid Cloud and Quantum Computing

IBM is not attempting to outspend Microsoft, Amazon or Google on public cloud capacity. It is also not the leading developer of frontier AI models.

Its strategy is to provide the infrastructure, data tools, security and governance that large organisations need to use AI across public clouds, private systems and existing data centres.

IBM is primarily selling the plumbing and control systems behind enterprise AI. It is not competing mainly through consumer chatbots. This positioning can be valuable because banks, insurers and governments care about security, reliability and control. However, IBM faces pressure from both directions.

Cloud companies can bundle competing data and AI tools into their platforms. At the same time, AI-assisted coding can reduce the labour required for consulting and legacy-system modernisation.

Do not confuse IBM’s AI book of business with revenue

IBM has reported a generative AI “book of business” exceeding $12.5 billion. That figure combines cumulative software transaction revenue, new software-as-a-service (SaaS) annual contract value and consulting signings since IBM began tracking the opportunity. 

It is not $12.5 billion of annual revenue. It is also not ARR. The figure demonstrates customer engagement, but it should not be valued like recurring sales.

IBM and Red Hat’s $5 billion Lightwell initiative could create another commercial opportunity by helping companies verify and fix open-source software vulnerabilities. Commercial offerings launched on July 8, but IBM has not disclosed enough revenue data to treat Lightwell as an offset to the Q2 weakness.

Quantum remains a long-term IBM bet

IBM has one of the strongest technical positions in quantum computing. It has deployed more than 90 systems, built a network of over 340 organisations and signed more than $1.1 billion of contracts since 2017.

The company plans to invest more than $10 billion over five years, target quantum advantage in 2026 and deliver the fault-tolerant Starling system in 2029. IBM is also contributing $1 billion to Anderon, a proposed quantum wafer foundry supported by $1 billion of US CHIPS incentives.

IBM’s quantum roadmap and Reuters support the technical leadership case. The financial case is less mature. Susquehanna values IBM’s quantum business at $65 per share, equivalent to approximately $61 billion using 940 million shares. That compares with more than $1.1 billion of cumulative contracts since 2017.

This is not a direct valuation comparison, since investors value future markets rather than only current revenue. It does show how much of the quantum valuation depends on future technical and commercial milestones.

Quantum is an option on future earnings. It cannot substitute for weak software execution today.

How to Evaluate IBM Across Three Investment Time Horizons: The 3-Clock Test

IBM’s different businesses should be judged over different periods. Reading IBM well means keeping three clocks running at once. Mixing them together can lead investors to the wrong conclusion. Here’s a three-clock test for investors to evaluate IBM:

• The quarter clock asks whether customer spending was merely delayed.
• The compounding clock asks whether IBM’s high-margin software and cash flow can grow consistently without relying mainly on acquisitions.
• The option clock covers projects such as quantum computing that may become valuable but are unlikely to determine next quarter’s earnings.

Most of the argument about IBM this week is really an argument about which clock matters most. The quarter clock is real and measurable. The decade clock is a genuine, unresolved debate rather than a settled bear case. The bet clock is why a stock that just fell 20% still has firms attaching $35 to $65 a share to a computer that will not be commercially proven for years.

The bet itself is worth defining rather than just naming. Today's quantum computers make errors so often that their answers cannot be fully trusted for the hardest, most valuable problems, roughly the way a phone line with constant static can carry a conversation but not a bank transfer. A fault-tolerant quantum computer is one built to detect and correct those errors as it runs, the digital equivalent of finally getting a clean line. IBM has said it expects its first fault-tolerant system by 2029 and the first verified cases of real quantum advantage as soon as later this year. Nobody, including IBM, is claiming that line is clean yet.

The current evidence supports a clear conclusion: this was a valuation reset triggered by a genuine fundamental warning. It was not simply a market overreaction, but it is also not yet proof that IBM’s entire strategy is broken.

IBM Stock Outlook: What Wall Street Analysts Are Saying

The spread of opinion on IBM stock week is unusually wide for one stock.

Sources: HSBC, UBS, J.P. Morgan, Susquehanna, Barclays, Benzinga and Citi.

Note: Every analyst target below predates the preliminary Q2 warning and may be revised. 

The $191 to $375 range represents a 96% difference. Analysts disagree mainly about two things:

1. How durable IBM’s core software cash flow will be.
2. How much value quantum deserves before it generates significant profit.

Is IBM Stock Undervalued After Q2 Earnings Warning?

At the June peak, investors were paying for sustained cash-flow growth. At the implied pre-market low, the valuation could tolerate moderate contraction. IBM is therefore materially less expensive, but it is not automatically undervalued.

The calculation depends on IBM maintaining the previously implied $15.73 billion FCF target. If 2026 free cash flow remained flat at 2025’s $14.73 billion, the indicated price-to-FCF multiple would be approximately 14.1x instead of 13.2x.

Source: MarketWatch, Investing.com, IBM’s 2025 annual report, Internal Calculation
Model assumptions: approximately 940 million shares, $15.73 billion of starting FCF, a 9% cost of equity, 3% long-term growth and five explicit forecast years. 

Here, FCF yield compares annual free cash flow with market value. A higher yield normally indicates a less demanding valuation, provided the cash flow is sustainable.

What Investors Should Watch in IBM Earnings on July 22

The July 22 earnings call is the real decision point. Five questions matter most:

1. Will IBM maintain its full-year revenue and free cash flow guidance?
   The valuation depends heavily on the previous cash flow outlook.
2. What was software growth excluding Confluent and currency?
   This will show whether IBM’s existing software operations are growing.
3. Were the large deals delayed or lost?
   Management should disclose how many have closed since quarter-end.
4. Why did IBM Z and Transaction Processing miss?
   A temporary purchase delay would be less serious than weaker demand or pricing.
5. Can IBM protect margins while funding acquisitions and quantum investment?
   Strategic investment creates value only if it eventually improves cash generation.

The next update can be assessed through three scenarios:

Is IBM Stock a Buy-on-Dip Opportunity After the 24% Drop?

IBM's numbers are preliminary and could move modestly by July 22. The evidence does not support treating IBM stock as an automatic buy-the-dip opportunity. It also does not support declaring the company’s AI, hybrid-cloud or quantum strategy broken.

• Bull case: Software still grew, the generative AI book of business keeps compounding off a base above $12.5 billion, the dividend was just raised for a 31st straight year, and two analysts raised targets the same morning the stock fell 20%.
• Bear case: A specific, company-confirmed hardware cycle is decelerating harder than IBM itself predicted, a real and growing share of enterprises are experimenting with building AI-assisted software in-house instead of buying it, and the stock was priced closer to perfection than to caution before this week began

IBM’s gross debt reached $66.4 billion following a major acquisition. Meanwhile, quantum could require years of investment before producing material profit. The lower price creates better valuation optionality, not automatic confirmation that the stock is cheap.

Investing before July 22 is effectively a bet that the delayed deals will close and the free cash flow outlook will survive. Waiting for the full results removes two major uncertainties: organic software growth and updated guidance. Existing investors should evaluate IBM primarily through sustainable software growth and free cash flow, not through the quantum narrative alone.

Bottom line: IBM’s preliminary Q2 results revealed a genuine execution and growth problem, but not yet a structural collapse. The stock is significantly less demanding after falling as much as 24%. Whether it is genuinely cheaper or simply reflecting weaker earnings quality depends on the disclosures arriving on July 22.